| mishravikashkumar650@gmail.com |
| Business Type | Exporter, Supplier, Trader |
| Composition | Ponatinib Hydrochloride |
| Dosage | 45mg |
| Features | Targeted Therapy,Chronic Leukemia Treatment,Improved Survival Rates,Effective Medication,45mg Dosage |
| Click to view more | |
Product Details
Ponaxen is a targeted prescription medication containing the active ingredient ponatinib. It is used to treat adult patients with specific types of blood cancers, such as resistant Chronic Myeloid Leukemia (CML) and Philadelphia chromosome- positive Acute Lymphoblastic Leukemia (Ph+ ALL). It is particularly known for treating cases with the T3151 mutation.
Raise your Query
Hi! Simply click below and type your query.
Our experts will reply you very soon.